Medidata Solutions, Inc. Selected By ASLAN Pharmaceuticals As Enterprise-Wide Technology Platform For Enhancing Clinical Development

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company. ASLAN’s adoption of the industry-leading Medidata Clinical Cloud™ supports the company’s strategy of maximizing the value of its in-licensed drug portfolio by conducting high quality, efficient clinical development in Asia.

Help employers find you! Check out all the jobs and post your resume.